Asia Business News | Sunday, September 07, 2008
RSS 2.0  
Benitec Limited (ASX:BLT) Delays Capital Raising Pending Restructure Of Relationship With CSIRO



About BENITEC LIMITED

Benitec is an Australian biotechnology company focused on licensing its extensive intellectual property portfolio and developing therapeutics to treat serious diseases using its proprietary ddRNAi technology. Its current therapeutic program is focused on Human Immunodeficiency Virus (HIV). For additional information, please visit www.benitec.com


 
   BENITEC LIMITED  
   ABN NEWSWIRE